Literature DB >> 12027115

Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry.

Dan J Stein1, Herman G M Westenberg, Michael R Liebowitz.   

Abstract

Awareness that an amygdala-based fear circuit plays a crucial role in mediating fear conditioning as well as anxiety symptoms is growing. The efficacy of selective serotonin reuptake inhibitors in certain anxiety disorders has been argued to reflect their ability to modulate this circuit. Whether additional neurocircuits play a differentiating role in specific anxiety disorders, such as social anxiety disorder and generalized anxiety disorder (GAD), is an ongoing subject of investigation. A review of the literature suggests that in social anxiety disorder, dopaminergically mediated striatal circuits may also be important, while in GAD, there may be abnormalities of prefrontal areas. Future work will undoubtedly clarify how genetic and environmental factors interact to fashion the neurocircuitry that mediates anxiety symptoms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027115

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  23 in total

Review 1.  Animal models of anxiety disorders.

Authors:  Joachim D K Uys; Dan J Stein; Willie M U Daniels; Brian H Harvey
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

2.  A 2010 evidence-based algorithm for the pharmacotherapy of social anxiety disorder.

Authors:  Dan J Stein; David S Baldwin; Borwin Bandelow; Carlos Blanco; Leonardo F Fontenelle; Sing Lee; Hisato Matsunaga; David Osser; Murray B Stein; Michael van Ameringen
Journal:  Curr Psychiatry Rep       Date:  2010-10       Impact factor: 5.285

3.  The experience of emotion.

Authors:  Lisa Feldman Barrett; Batja Mesquita; Kevin N Ochsner; James J Gross
Journal:  Annu Rev Psychol       Date:  2007       Impact factor: 24.137

Review 4.  Revisiting the serotonin-aggression relation in humans: a meta-analysis.

Authors:  Aaron A Duke; Laurent Bègue; Rob Bell; Tory Eisenlohr-Moul
Journal:  Psychol Bull       Date:  2013-02-04       Impact factor: 17.737

Review 5.  Transcription factor AP-2 and monoaminergic functions in the central nervous system.

Authors:  M Damberg
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

6.  Allelic Variation of Risk for Anxiety Symptoms Moderates the Relation Between Adolescent Safety Behaviors and Social Anxiety Symptoms.

Authors:  Sarah A Thomas; Justin W Weeks; Lea R Dougherty; Melanie F Lipton; Samantha E Daruwala; Kathryn Kline; Andres De Los Reyes
Journal:  J Psychopathol Behav Assess       Date:  2015-05-19

7.  Temporal sequence of comorbid alcohol use disorder and anorexia nervosa.

Authors:  Jessica H Baker; Laura M Thornton; Michael Strober; Harry Brandt; Steve Crawford; Manfred M Fichter; Katherine A Halmi; Craig Johnson; Ian Jones; Allan S Kaplan; Kelly L Klump; James E Mitchell; Janet Treasure; D Blake Woodside; Wade H Berrettini; Walter H Kaye; Cynthia M Bulik
Journal:  Addict Behav       Date:  2012-10-08       Impact factor: 3.913

8.  Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.

Authors:  Meera Sheffrin; Henry C Driscoll; Eric J Lenze; Benoit H Mulsant; Bruce G Pollock; Mark D Miller; Meryl A Butters; Mary Amanda Dew; Charles F Reynolds
Journal:  J Clin Psychiatry       Date:  2009-02-10       Impact factor: 4.384

Review 9.  The neurocircuitry of fear, stress, and anxiety disorders.

Authors:  Lisa M Shin; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

10.  Stimulus-reinforcement-based decision making and anxiety: impairment in generalized anxiety disorder (GAD) but not in generalized social phobia (GSP).

Authors:  J DeVido; M Jones; M Geraci; N Hollon; R J R Blair; D S Pine; K Blair
Journal:  Psychol Med       Date:  2008-12-22       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.